Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The CaMKII D135N mutation blocks kinase activity and reduces GluN2B binding.

Molecular pharmacology·2026
Same author

Early Life Exposure to Δ<sup>9</sup>-Tetrahydrocannabinol Causes Persistent Growth, Behavior, and Bioenergetic Outcomes in Zebrafish.

Cannabis and cannabinoid research·2025
Same author

Sex differences in the capacity of minor phytocannabinoids to attenuate nociceptive insults in HIV-1 Tat-expressing mice.

NeuroImmune pharmacology and therapeutics·2025
Same author

The CaMKII D135N mutation blocks kinase activity and reduces GluN2B binding.

bioRxiv : the preprint server for biology·2025
Same author

CaMKII monomers are sufficient for GluN2B binding, co-condensation, and synaptic potentiation.

bioRxiv : the preprint server for biology·2025
Same author

The neuroprotective γ-hydroxybutyrate analog 3-hydroxycyclopent-1-enecarboxylic acid does not directly affect CaMKIIα autophosphorylation at T286 or binding to GluN2B.

Molecular pharmacology·2025

Related Experiment Video

Updated: May 31, 2026

Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke
11:32

Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke

Published on: January 3, 2025

CaMKII in cerebral ischemia.

Steven J Coultrap1, Rebekah S Vest, Nicole M Ashpole

  • 1Department of Pharmacology, University of Colorado Denver-School of Medicine, Aurora, CO 80045, USA.

Acta Pharmacologica Sinica
|June 21, 2011
PubMed
Summary

Excessive glutamate release causes neuronal death. Ca²⁺/calmodulin-dependent protein kinase II (CaMKII) activity, particularly autonomous CaMKII, is explored as a neuroprotection target against excitotoxicity and cerebral ischemia.

More Related Videos

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse
08:27

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse

Published on: July 25, 2011

Two-vessel Occlusion Mouse Model of Cerebral Ischemia-reperfusion
07:34

Two-vessel Occlusion Mouse Model of Cerebral Ischemia-reperfusion

Published on: March 1, 2019

Related Experiment Videos

Last Updated: May 31, 2026

Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke
11:32

Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke

Published on: January 3, 2025

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse
08:27

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse

Published on: July 25, 2011

Two-vessel Occlusion Mouse Model of Cerebral Ischemia-reperfusion
07:34

Two-vessel Occlusion Mouse Model of Cerebral Ischemia-reperfusion

Published on: March 1, 2019

Area of Science:

  • Neuroscience
  • Cellular Biology
  • Biochemistry

Background:

  • Ischemic insults lead to excitotoxicity via excessive glutamate release and Ca²⁺ overload, causing neuronal cell death.
  • Ca²⁺/calmodulin-dependent protein kinase II (CaMKII) mediates physiological glutamate signaling, synaptic plasticity, and learning.
  • Autophosphorylation of CaMKII at T286 creates autonomous activity, crucial for synaptic plasticity.

Purpose of the Study:

  • To review the dual role of CaMKII in neuronal death and survival.
  • To discuss CaMKII's function in excitotoxicity and cerebral ischemia.
  • To highlight autonomous CaMKII activity as a potential neuroprotection target.

Main Methods:

  • Literature review of past findings on CaM kinase functions.
  • Discussion of potential mechanisms in excitotoxicity and cerebral ischemia.
  • Focus on CaMKII regulation and its role in neuronal fate.

Main Results:

  • Autonomous CaMKII activity is implicated in both neuronal death and survival.
  • CaMKII plays a significant role in excitotoxicity and cerebral ischemia.
  • Autonomous CaMKII activity is a potential therapeutic target for neuroprotection.

Conclusions:

  • CaMKII's complex role in neuronal fate requires further investigation.
  • Understanding CaMKII regulation is key to developing neuroprotective strategies.
  • Targeting autonomous CaMKII may offer a novel approach for treating ischemic brain injury.